Cognition Therapeutics Inc CGTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 08/12/22 EDT
2.26UNCH (UNCH)
Volume
1,320
Close
2.26quote price arrow down-0.11 (-4.64%)
Volume
124,618
52 week range
1.50 - 13.80
Loading...
  • Open2.30
  • Day High2.45
  • Day Low2.22
  • Prev Close2.37
  • 52 Week High13.80
  • 52 Week High Date10/08/21
  • 52 Week Low1.50
  • 52 Week Low Date06/22/22

Key Stats

  • Market Cap51.32M
  • Shares Out22.71M
  • 10 Day Average Volume2.93M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-64.24

KEY STATS

  • Open2.30
  • Day High2.45
  • Day Low2.22
  • Prev Close2.37
  • 52 Week High13.80
  • 52 Week High Date10/08/21
  • 52 Week Low1.50
  • 52 Week Low Date06/22/22
  • Market Cap51.32M
  • Shares Out22.71M
  • 10 Day Average Volume2.93M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-64.24

RATIOS/PROFITABILITY

  • EPS (TTM)-0.83
  • P/E (TTM)-2.72
  • Fwd P/E (NTM)-2.54
  • EBITDA (TTM)-32.387M
  • ROE (TTM)-
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/17/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cognition Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Cognition Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system (CNS) and retina. It is focused on developing a pipeline of small molecule product candidates that targets the sigma-2 receptor (S2R) complex, a key regulator of the cellular damage response for diseases such as Alzheimer’s...
Jack Khattar
Non-Executive Independent Chairman of the Board
Lisa Ricciardi
President, Chief Executive Officer, Director
James O'Brien CPA
Chief Financial Officer
Address
Suite 261, 2403 Sidney Street
Pittsburgh, PA
15203
United States

Top Peers

SYMBOLLASTCHG%CHG
EVAX
Evaxion Biotech A/S
2.93+0.13+4.64%
RUBY
Rubius Therapeutics Inc
0.7999+0.0418+5.51%
NMTR
9 Meters Biopharma Inc
0.2691+0.0051+1.93%
GNPX
Genprex Inc
1.77+0.27+18.00%
ETNB
89Bio Inc
4.35+0.27+6.62%